Press Release Wisdom Bridge Authors’ First Founding Author Completes Phase One of The Living Bridge Aug 4
Press Release Sarcomatrix Applies SarcoVista™ Translational Modeling to First-in-Human Dose Selection for S-969 Jul 27
Press Release Sarcomatrix Therapeutics Opens Accredited Investor Round for Once-Daily Pill Designed to Address Duchenne Regardless of Genetic Mutation Jul 23